A Retrospective Cohort Study of Vancomycin Dose Reductions Among Home Infusion Patients Post-Hospitalization
Infusion Journal · 2022
DOI: 10.70776/cnaj9890 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Infusion Journal, 2022. Verfasst von Cheyenne Johnson und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Patients treated with intravenous (IV) vancomycin in the hospital often require outpatient parenteral antimicrobial therapy (OPAT) after discharge for the continuation of therapy. Despite vigilant monitoring, nephrotoxicity is a common adverse drug event associated with vancomycin in the home infusion setting.
Methods
This multi-center retrospective cohort study included adult patients from the North Central United States receiving trough-based IV vancomycin dosing for osteomyelitis between April 1, 2021, and June 30, 2021. The primary objective was to determine the percentage of patients requiring vancomycin dose reductions upon transition from an inpatient setting to home infusion services. Secondary outcomes evaluated the incidence of acute kidney injury (AKI) and rehospitalization rates due to AKI.
Results
A total of 94 patients were included and evaluated for dose reductions of vancomycin. Of these, 47 (50%) patients required dose reductions throughout therapy, with 24 (51%) reductions occurring within the first 7 days post-hospitalization. Nine (9.5%) patients developed AKI from vancomycin within 2-7 days post-hospitalization, and 4 (4.3%) patients required readmission due to AKI.
Conclusions
Most patients in this study required vancomycin dose reductions within the first 7 days post-hospitalization, indicating the importance of careful monitoring upon transition to home infusion services. Patients receiving vancomycin dose reductions before hospital discharge did not experience AKI or rehospitalization. Empiric vancomycin dose modifications may be reasonable with proper clinical judgment but should be monitored closely to ensure therapeutic drug levels and patient safety. Keywords: Home infusion, vancomycin, outpatient parenteral antimicrobial therapy, therapeutic drug monitoring, nephrotoxicity, MRSA
Zitieren
APA
Johnson, C., Decker, D., & Giannakos, M. (2022). A Retrospective Cohort Study of Vancomycin Dose Reductions Among Home Infusion Patients Post-Hospitalization. Infusion Journal. https://doi.org/10.70776/cnaj9890
Vancouver
Johnson C, Decker D, Giannakos M. A Retrospective Cohort Study of Vancomycin Dose Reductions Among Home Infusion Patients Post-Hospitalization. Infusion Journal. 2022. doi:10.70776/cnaj9890
BibTeX
@article{Johnson2022,
author = {Johnson, Cheyenne and Decker, Daniel and Giannakos, Maria},
title = {A Retrospective Cohort Study of Vancomycin Dose Reductions Among Home Infusion Patients Post-Hospitalization},
journal = {Infusion Journal},
year = {2022},
doi = {10.70776/cnaj9890}
}
EUVIMED